| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/23/2001 | DE10008128A1 Endoparasiticide composition effective on topical administration, comprises solution of depsipeptide in solvent such as 1,2-isopropylidene-glycerol |
| 08/23/2001 | DE10006572A1 Oligonucleotid-Konjugate Oligonucleotide conjugates |
| 08/23/2001 | DE10006570A1 Nicht toxisches MR-Kontrastmittel Non-toxic MR contrast agents |
| 08/23/2001 | DE10005936A1 Creme, insbesondere zur äußeren Anwendung auf der Nasenhaut Cream, especially for external use on the skin of the nose |
| 08/23/2001 | CA2400374A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | CA2400346A1 Method of filtration of a dairy stream |
| 08/23/2001 | CA2400205A1 Modification of biopolymers for improved drug delivery |
| 08/23/2001 | CA2400178A1 Nail lacquer pharmaceutical composition |
| 08/23/2001 | CA2399822A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation |
| 08/23/2001 | CA2399219A1 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase |
| 08/23/2001 | CA2398935A1 Single phase gels for the prevention of adhesions |
| 08/23/2001 | CA2398691A1 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 08/23/2001 | CA2398395A1 Conjugates targeted to target receptors |
| 08/23/2001 | CA2396793A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | CA2395038A1 Matrix metalloproteinase inhibitors |
| 08/23/2001 | CA2337616A1 Method of increasing the bioavailability and tissue penetration of azithromycin |
| 08/22/2001 | EP1125954A2 Preparation and use of water soluble or water dispersible polyether containing polymers |
| 08/22/2001 | EP1125590A2 Bioadhesive composition |
| 08/22/2001 | EP1125577A2 Liquid drug delivery compositions |
| 08/22/2001 | EP1125576A1 Process for producing spherical fine particles containing drug |
| 08/22/2001 | EP1125574A2 Cosmetical and pharmaceutical oil-in-water emulsions of polyether polysiloxanes |
| 08/22/2001 | EP1124630A1 Method for preparing capsules consisting of a liquid active material core enclosed in a mineral coating |
| 08/22/2001 | EP1124594A1 Implant with cavities containing therapeutic agents |
| 08/22/2001 | EP1124592A2 Textured and porous silicone rubber |
| 08/22/2001 | EP1124582A1 Preservative system for topically administrable pharmaceutical compositions |
| 08/22/2001 | EP1124581A1 Transdermal delivery of medications using a combination of penetration enhancers |
| 08/22/2001 | EP1124576A2 Method for preparing solid phase conjugate vaccines |
| 08/22/2001 | EP1124570A2 Novel neuropilin/growth factor binding and uses thereof |
| 08/22/2001 | EP1124567A2 Buffered compositions for dialysis |
| 08/22/2001 | EP1124563A2 Methods and compositions for the prevention of tolerance to medications |
| 08/22/2001 | EP1124557A2 Pharmaceutical composition |
| 08/22/2001 | EP1124551A2 Delta 9 tetrahydrocannabinol (delta 9 thc) solution metered dose inhalers and methods of use |
| 08/22/2001 | EP1124549A1 Water-miscible pharmaceutical compositions of paclitaxel |
| 08/22/2001 | EP1124544A1 Dry powder pharmaceutical formulation |
| 08/22/2001 | EP1124543A1 Controlled release formulation for water soluble drugs |
| 08/22/2001 | EP1124542A1 Capsules with porous mineral cortex |
| 08/22/2001 | EP1124541A1 Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as a coating agent, a binding agent and/or as a film-forming auxiliary agent in pharmaceutical forms of administration |
| 08/22/2001 | EP1124539A1 Pharmaceutical formulation comprising omeprazole |
| 08/22/2001 | EP1124538A2 Composition for the parenteral administration of active agents |
| 08/22/2001 | EP1124537A1 Propofol composition |
| 08/22/2001 | EP1124536A1 Propofol composition comprising pentetate |
| 08/22/2001 | EP1124535A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 08/22/2001 | EP1124534A1 Expandable gastroretentive therapeutical system with prolonged stomach retention time |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | EP1124444A1 Sweetener |
| 08/22/2001 | EP1124443A1 Solid delivery systems for aroma ingredients |
| 08/22/2001 | EP1105518A4 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 08/22/2001 | EP0991402A4 Poly(vinyl alcohol) cryogel |
| 08/22/2001 | EP0973559B1 Method and composition for coating wound or protecting animal skin |
| 08/22/2001 | EP0935454B1 Cosmetic and/or pharmaceutical preparations |
| 08/22/2001 | EP0907633B1 New synthetic catechol derivatives, method for production and use thereof |
| 08/22/2001 | EP0836472B1 Therapeutic effervescent compositions |
| 08/22/2001 | EP0833611B1 A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 08/22/2001 | EP0831787B1 Composition for sustained release of human growth hormone |
| 08/22/2001 | EP0814766B1 Cosmetic and/or pharmaceutical preparations |
| 08/22/2001 | EP0696208B1 Oral drug delivery compositions |
| 08/22/2001 | CN1309666A Polymer composition of glucuronic acid glucosan |
| 08/22/2001 | CN1309570A Excipient |
| 08/22/2001 | CN1309567A FSH and FSH variant formulations, products and methods |
| 08/22/2001 | CN1309560A Prevention of migraine recurrence |
| 08/22/2001 | CN1309558A Transdermal patch and topical compositions comprising propylnorapomorphine |
| 08/22/2001 | CN1309556A Biodegradable sustained-release alginate gels |
| 08/22/2001 | CN1309555A Incorporation of active substances in carrier matrixes |
| 08/22/2001 | CN1309554A Biologically active composition |
| 08/22/2001 | CN1309553A Biologically active composition |
| 08/22/2001 | CN1309537A Coloration with pearly luster pigments in food and pharmaceutical sectors |
| 08/22/2001 | CN1308969A Biologic adhesive composition |
| 08/22/2001 | CN1069838C Stable microbubble suspensions as enhancement agent for ultrasound echography |
| 08/21/2001 | US6277892 Topical composition comprising sunless tanning agent and high molecular weight crosslinked cationic polymer based on dialkylaminoalkyl (meth)acrylate monomer or its quaternary ammonium or acid addition salt |
| 08/21/2001 | US6277888 Drug composition |
| 08/21/2001 | US6277880 Chemical compounds |
| 08/21/2001 | US6277863 Anticoagulant with reduced side effects |
| 08/21/2001 | US6277829 Dissolving azithromycin in solution of polybasic phosphate and citric acid; treatment of conjunctivitis, keratitis and blepharitis |
| 08/21/2001 | US6277828 Aqueous isotonic solutions containing human serum albumin, sodium chloride and citric acid, suitable for lyophilization, useful for the treatment of alzheimer's disease |
| 08/21/2001 | US6277824 Enhancing or inhibiting cadherin-mediated functions comprising a his-ala-val sequence binding motif, an peptidomimetic or an antibody that binds to such a motif |
| 08/21/2001 | US6277806 Enzyme fused to a heavy chain immunoglobulin raised in camelidae and has a specificity for non-colored compounds present in stains and fabrics, surfactant and transition metal catalyst |
| 08/21/2001 | US6277600 Trimeric chimera protein and collagen matrix containing chimera protein |
| 08/21/2001 | US6277599 Monoclonal antiboby for the preferential killing of tumors; for diagnosis of cancer; for the treatment of cancer |
| 08/21/2001 | US6277412 A core and an enteric coating, the core including, as a pharmaceutical active compound, 5-aminosalicylic acid homogeneously dispersed in a non gel-forming polymer matrix which extends through the entire core |
| 08/21/2001 | US6277410 Mixture comprises at least one block copolymer with ethylene(oxide) content of 50% or less, and at least one block copolymer with ethylene(oxide) content of 50% or more. |
| 08/21/2001 | US6277405 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
| 08/21/2001 | US6277403 Poly(oxy(ethyl-1,2-ethanediyl)oxycarbonyl-1,4-phenyleneoxycarb onyl-1, 4-phenylenecarbonyloxy-1,4-phenylenecarbonyl or poly(oxy(decanyl-1,2-ethanediyl)oxycarbonyl-1,4-phenyleneoxyca rbonyl-1, 4-phenylenecarbonyloxy-1,4-phenylenecarbonyl) |
| 08/21/2001 | US6277401 Drug delivery device |
| 08/21/2001 | US6277395 Swallowing-assistive drink |
| 08/21/2001 | US6277386 Cosmetic |
| 08/21/2001 | US6277367 Erythropoietin solution preparation |
| 08/21/2001 | US6277366 Noncrosslinked quaternized aminoalkyl acrylate anion exchange resins, antilipemic agent |
| 08/21/2001 | US6277365 Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent |
| 08/21/2001 | US6277363 Containing activated chlorine dioxide and disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, or sodium monofluorophosphate |
| 08/21/2001 | US6277186 Slurrying starch and low molecular weight carbohydrate in aqueous solution to form a blend, dehydrating blend to anhydrous conditions, heat treating dehydrated blend at temperature and for time sufficient to inhibit starch |
| 08/21/2001 | CA2319308C Pharmaceutical agents |
| 08/21/2001 | CA2180554C Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds |
| 08/21/2001 | CA2121889C Production and use of multimeric hemoglobins |
| 08/21/2001 | CA2052840C Lactoneotrehalose, and it's preparation and uses |
| 08/18/2001 | CA2337484A1 Fatty acid-containing composition |
| 08/16/2001 | WO2001059458A1 Specific monoclonal antibody against terbinafine |
| 08/16/2001 | WO2001059110A2 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059087A2 Compositions for transfecting nucleic acids and their use |
| 08/16/2001 | WO2001059078A2 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 08/16/2001 | WO2001058961A1 Gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters or mixtures thereof |